CSPC Innovation Pharmaceutical Co Ltd Class A
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and h… Read more
CSPC Innovation Pharmaceutical Co Ltd Class A - Asset Resilience Ratio
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has an Asset Resilience Ratio of 6.93% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how CSPC Innovation Pharmaceutical Co Ltd Class A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down CSPC Innovation Pharmaceutical Co Ltd Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥430.45 Million | 6.93% |
| Total Liquid Assets | CN¥430.45 Million | 6.93% |
Asset Resilience Insights
- Limited Liquidity: CSPC Innovation Pharmaceutical Co Ltd Class A maintains only 6.93% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CSPC Innovation Pharmaceutical Co Ltd Class A Industry Peers by Asset Resilience Ratio
Compare CSPC Innovation Pharmaceutical Co Ltd Class A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
General Mills Inc
NYSE:GIS |
Packaged Foods | 2.10% |
|
Maniker F & G Co. Ltd
KQ:195500 |
Packaged Foods | 12.96% |
|
Xiwang Foodstuffs Co Ltd
SHE:000639 |
Packaged Foods | 0.18% |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716 |
Packaged Foods | -0.19% |
|
CNFC Overseas Fishery Co Ltd
SHE:000798 |
Packaged Foods | -2.62% |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895 |
Packaged Foods | 1.48% |
|
Xinjiang Chalkis Co Ltd
SHE:000972 |
Packaged Foods | 0.02% |
|
Daehan Flour Mills Co Ltd
KO:001130 |
Packaged Foods | 21.91% |
Annual Asset Resilience Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A (2019–2024)
The table below shows the annual Asset Resilience Ratio data for CSPC Innovation Pharmaceutical Co Ltd Class A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.81% | CN¥470.09 Million | CN¥6.02 Billion | -5.02pp |
| 2021-12-31 | 12.82% | CN¥413.59 Million | CN¥3.23 Billion | +1.93pp |
| 2020-12-31 | 10.90% | CN¥321.94 Million | CN¥2.95 Billion | -22.76pp |
| 2019-12-31 | 33.66% | CN¥960.09 Million | CN¥2.85 Billion | -- |